Status:
COMPLETED
Towards an Early Integration of Palliative Care in Oncology
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Fondation de France
Conditions:
Metastatic Cancer
Palliatives Treatments
Eligibility:
All Genders
18+ years
Brief Summary
The primary objective of the study is to describe the nature and to estimate the prevalence the health needs of patients with metastatic cancer and their main caregivers, between the period from diagn...
Detailed Description
This is a descriptive, transversal, multicenter study, which will be performed in healthcare facilities in Ile de France area. Each investigator center will be composed by oncologist / palliative car...
Eligibility Criteria
Inclusion
- Patients ≥ 18 years;
- Diagnosed metastatic cancer;
- Outpatient or inpatient care at a participating site to the study;
- Affiliation to the social security scheme;
- Patient informed and non-opposed to participate to the study.
Exclusion
- Testicular or choriocarcinoma ovarian cancer;
- Hematology cancer;
- No understanding french language;
- Unable to express if needed his non-opposition opinion, according to physician investigator;
- Visually impaired, hearing impaired or aphasic.
Key Trial Info
Start Date :
June 2 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 21 2024
Estimated Enrollment :
361 Patients enrolled
Trial Details
Trial ID
NCT05339945
Start Date
June 2 2022
End Date
October 21 2024
Last Update
December 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mobile palliative care and support team, Ambroise Paré hospital, APHP
Boulogne-Billancourt, France, 92100